Visualization of Endogenous ERK1/2 in Cells with a Bioorthogonal Covalent ProbeJames Sipthorp(Babraham Institute), Tom D. Heightman(AstraZeneca (Brazil))Bioconjugate ChemistryApril 28, 201710.1021/acs.bioconjchem.7b00152Cited by 10SaveCiteExport RISWatch citationsRelated PapersQuantitation of ERK1/2 inhibitor cellular target occupancies with a reversible slow off-rate probe|Chemical Science|2018|14Quantitation of ERK1/2 inhibitor cellular target occupancies with a reversible slow off-rate probe.|PubMed|2018|7